Aster DM Healthcare concludes separation of India and GCC businesses
The company plans to add 1700 beds by FY27 through the organic route
The company plans to add 1700 beds by FY27 through the organic route
The MDC business produces components for medical device manufacturers globally with a focus on precious metal alloys and nitinol
The plan essentially was to separate Aster’s India and GCC businesses to unlock long-term value
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
From only 80 Jan Aushadhi Kendras in 2014, there are around 11,000 units operating across the country today
The plan is to set up an ultramodern Solvent Recovery Plant for third party purposes
Subscribe To Our Newsletter & Stay Updated